[{"id":"22c4a7b3-005a-45aa-b942-f2db0868d6b2","acronym":"","url":"https://clinicaltrials.gov/study/NCT05323201","created_at":"2022-04-12T14:53:00.485Z","updated_at":"2024-07-02T16:36:13.151Z","phase":"Phase 1/2","brief_title":"Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer","source_id_and_acronym":"NCT05323201","lead_sponsor":"The Affiliated Hospital of Xuzhou Medical University","biomarkers":" CD276","pipe":" | ","alterations":" CD276 expression","tags":["CD276"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD276 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • fhB7H3.CAR-Ts"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 02/10/2022","start_date":" 02/10/2022","primary_txt":" Primary completion: 02/10/2024","primary_completion_date":" 02/10/2024","study_txt":" Completion: 02/10/2027","study_completion_date":" 02/10/2027","last_update_posted":"2022-04-12"},{"id":"faed0dd2-a4f9-464d-8199-fe65794a9804","acronym":"","url":"https://clinicaltrials.gov/study/NCT05211557","created_at":"2022-01-29T18:05:02.809Z","updated_at":"2024-07-02T16:36:17.869Z","phase":"Phase 1/2","brief_title":"Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer","source_id_and_acronym":"NCT05211557","lead_sponsor":"The Affiliated Hospital of Xuzhou Medical University","biomarkers":" CD276 • MUC16","pipe":" | ","alterations":" CD276 expression","tags":["CD276 • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD276 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fhB7H3.CAR-Ts"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 11/16/2021","start_date":" 11/16/2021","primary_txt":" Primary completion: 08/31/2023","primary_completion_date":" 08/31/2023","study_txt":" Completion: 08/31/2026","study_completion_date":" 08/31/2026","last_update_posted":"2022-01-27"}]